Launching Flonase Allergy Relief lifts GSK in 2015

4 February 2016 - Deborah Wilkes

Archived

Switching Flonase to OTC status helped lift GlaxoSmithKline Consumer Healthcare's pro forma sales in the US by 22% at constant exchange rates during 2015.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: